Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome

NCT05658692 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

DEVICE: protective ventilation
BEHAVIORAL: prone position ventilation
DRUG: glucocorticoid therapy
OTHER: restrictive fluid resuscitation
BIOLOGICAL: Thymosin Alpha
DRUG: Muscle relaxant therapy
OTHER: Integrated Chinese and Western Medicine Treatment
DRUG: statin therapy
COMBINATION_PRODUCT: anti-infective treatment
DEVICE: Extracorporeal Membrane Oxygenation（ECMO）
GENETIC: stem cell therapy
DRUG: Sedative analgesia/muscle relaxant therapy
DRUG: inotropes therapy
DRUG: Vasoactive drug therapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]